Member Info for Timber1234

PB - if you think the CEO of a company is full of BS and isn’t the right man for the job, it’s time to sell.

Why on earth would anyone invest in a CEO (which ultimately one is doing when one invests in any company) who they think speaks untruths, intentionally misguides investors and thus have little or no faith in?

I watched the interview at the time, along with every other interview CF has given in the past 12 months. And, as per my previous post, no mention of the word “promise”. He has never ‘promised’ anything.

I guess it depends on one’s level of expectation. For me, a £10m contract and 90% of 2022 forecast revenue already in the bag (excl. potential Covid contract revenue) is very satisfactory and far from cause for disappointment.

Not once has CF uttered the word “promise.” No one can control the share price. There are far too many forces in play for one man to have the power to control the share price of any company.

I think you’ll find revenue is flourishing - profit will follow. Too many investors focus on the short term share price and lose sight of the fundamentals of a company.

If a £10m contact RNS isn’t enough for some impatient investors then it’s time for the m to sell.

Thanks FTC. Well worth posting and reminding those who can’t see beyond the current SP.

https://m.youtube.com/watch?v=n5BUghTUOzg

Great interview. Very insightful and reassuring. Thanks Elric.

BeContrarian - great, insightful message. I completely agree.

One needs to take CF’s previous vocal enthusiasm with a pinch of ‘Irish’ salt and focus on the fundamentals, regardless of casual timelines suggested by an enthusiastic, ambitious and optimistic CEO. I’d much rather be invested in a company run by a energetic, ambitious CEO with significant, personal skin in the game and bags of self-belief, along with confidence in his team, than most of the loss making companies on AIM run by individuals out to make money at the expense of their shareholders.

I also believe in CF and the best is definitely yet to come. I do understand folks bailing out but at this price ORPH is a steal and I’m confident future news flow will attract the attention this healthy company and quality BoD deserves.

GMAN - a good and valid point. Apologies re. the “weak” reference. Each to their own, as you quite rightly say. GL.

Good advice Moniman.
C U next Tuesday JB.

Friel, the man who increased the sp by 600% over 12 months; and continues to increase revenue, profit and
international interest. The sp is down from a high of 46p, proving he can take it those levels and will do so again the problem is too many investors are out for a ‘quick buck’ and don’t recognise when to hold a value stock. - this is a minimum 24 month investment from now.
More to the point, if this is genuinely how you feel, why on earth are you backing a man you have no belief in? This is a question you continually avoid answering, which ironically gives you zero credibility.

….that every rise gets heavily sold into. I was hoping the sell off last week has flushed out the weak and nervous shareholders. Do these people not recognise an undervalued company with massive potential when it’s staring them in the face!

Exactly SeenRight.

JB - “this business is done. Move on”
So why are earth are you:
1. Spending time posting on here? Have you nothing better to do?
2. Still invested? If indeed you are.
If your strategy is to remain invested in companies you think have no potential and enjoy undermining positive news they release, I strongly suggest you stop investing immediately.

ORPH surely has to play a significant role in this.

https://100days.cepi.net/

“A global network of clinical trial sites, labs, and a globally agreed set of “rules” for trials in a pandemic situation needs to be established. These trial approaches will help to streamline data sharing and vaccine approvals by regulators.”

ORPH surely has to play a significant role in this.

https://100days.cepi.net/

“A global network of clinical trial sites, labs, and a globally agreed set of “rules” for trials in a pandemic situation needs to be established. These trial approaches will help to streamline data sharing and vaccine approvals by regulators.”

Dubliner - Understood. Appreciate the clarification.

FC & Dubliner. Why don’t you contact Cathal and arrange your own podcast recording then?

The podcast recording is postponed until next week due to overwhelming interest. It seems the numerous emailed questions investors would like Elric to put to Cathal need to be processed to avoid duplication and maximise the time available.

Elric (founder of Small Company Champion, Lemming investors and organiser of recent ORPH and POLB investor presentation events) is recording the podcast with Cathal this evening. Just pay the subscription - it is a nominal amount and the majority, if not all, is donated to a worthwhile charity. Small Co. Champion’s and Lemming Investor’s insightful emails and podcasts are worth every penny.

I suspect that is the case. Fortunate timing for the newbies. Definitely an exciting and rewarding few months ahead. There’s no doubt about it.

Indeed. Thankfully. Confirming the fact there is still significant appetite for ORPH; contrary to what a few on here would have everyone believe.